Tonix Pharmaceuticals Holding Corp.

26 Main Street, Suite 101

Chatham, New Jersey 07928


December 30, 2020


United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:Tonix Pharmaceuticals Holding Corp.

Registration Statement on Form S-1 (File No. 333-251500)
Filed on December 18, 2020

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on January 4, 2021, or as soon as practicable thereafter.


Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.


  Very truly yours,
  By: /s/ Bradley Saenger
  Name: Bradley Saenger
  Title: Chief Financial Officer